The effect of OA treatment was evaluated measuring the fluorescence signal intensity of both P-tau and oligomeric tau protein, two biological markers associated with AD related neuronal degeneration, using the specific AT8 and T22 antibodies respectively. Here, MAPT is linked to Alzheimer disease.